Jun 4, 2021Frequently Asked Questions: The TRIPS waiver and the WTOEducational Material, Vaccine Equity, Access and Allocation
May 16, 2021COVID-19 Vaccine | Is government geared for Phase 2?Interviews, Vaccine Equity, Access and Allocation
May 11, 2021Private-public politics: State control crucial for vaccine equity and to stop queue-jumping by the richOpinion Pieces, Vaccine Equity, Access and Allocation
May 7, 2021Unsure vaccine waiver will help, some leaders urge exportsInterviews, Vaccine Equity, Access and Allocation
May 7, 2021African Activists Welcome US Support of COVID Vaccine WaiverInterviews, Vaccine Equity, Access and Allocation
May 6, 2021Ramaphosa welcomes US backing of move to suspend patents on Covid-19 vaccinesInterviews, Vaccine Equity, Access and Allocation
May 6, 2021US President Joe Biden’s administration ,announced support for a global waiver on patent protections for COVID-19 vaccines.Interviews, Vaccine Equity, Access and Allocation
May 6, 2021Hopes surge for boosted vaccine supply after U.S. voices support for waiving patents, even as uncertainty remainsInterviews, Vaccine Equity, Access and Allocation
May 6, 2021Fatima Hassan explains what US’s support for the waiver of IP rights for COVID-19 vaccines meansInterviews, Vaccine Equity, Access and Allocation
May 6, 2021HJI welcomes the US government support of the ‘TRIPS Waiver’Press Release, Vaccine Equity, Access and Allocation
May 5, 2021Patients in a Pandemic: From Advocacy to Action. Protecting rights and balancing responsibilities in an exhausted healthcare systemVaccine Equity, Access and Allocation, Webinars
May 5, 2021‘We’re not vaccinating – a 3rd wave of Covid-19 infections is thus inevitable’Interviews, Vaccine Equity, Access and Allocation
